The role of complement in ocular pathology

被引：58

作者：

Bora, Nalini S. ^{[1
]}

Jha, Purushottam ^{[1
]}

Bora, Puran S. ^{[1
]}

机构：

[1] Univ Arkansas Med Sci, Dept Ophthalmol, Jones Eye Inst, Little Rock, AR 72205 USA

来源：

SEMINARS IN IMMUNOPATHOLOGY | 2008年 / 30卷 / 02期

关键词：

complement system; complement regulatory proteins; eye; corneal inflammation; uveitis; age-related macular degeneration;

D O I：

10.1007/s00281-008-0110-y

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Functionally active complement system and complement regulatory proteins are present in the normal human and rodent eye. Complement activation and its regulation by ocular complement regulatory proteins contribute to the pathology of various ocular diseases including keratitis, uveitis and age-related macular degeneration. Furthermore, a strong relationship between age-related macular degeneration and polymorphism in the genes of certain complement components/complement regulatory proteins is now well established. Recombinant forms of the naturally occurring complement regulatory proteins have been exploited in the animal models for treatment of these ocular diseases. It is hoped that in the future recombinant complement regulatory proteins will be used as novel therapeutic agents in the clinic for the treatment of keratitis, uveitis, and age-related macular degeneration.

引用

页码：85 / 95

页数：11

共 99 条

[1] The simple design of complement factor H: Looks can be deceiving
Alexander, Jessy J.
Quigg, Richard J.
[J]. MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 123 - 132
[2] SEPARATION OF SELF FROM NON-SELF IN THE COMPLEMENT-SYSTEM
ATKINSON, JP
FARRIES, T
[J]. IMMUNOLOGY TODAY, 1987, 8 (7-8): : 212 - 215
[3] ATKINSON JP, 1980, CLIN IMMUNOLOGY, P219
[4] BANDO Y, 1989, Nippon Ganka Gakkai Zasshi, V93, P369
[5] Bardenstein DS, 1999, INVEST OPHTH VIS SCI, V40, P519
[6] LOCALIZATION OF THE COMPLEMENT MEMBRANE ATTACK COMPLEX INHIBITOR (CD59) IN HUMAN CONJUNCTIVA AND LACRIMAL GLAND
BARDENSTEIN, DS
DIETZ, Y
LASS, JH
MEDOF, ME
[J]. CURRENT EYE RESEARCH, 1994, 13 (12) : 851 - 855
[7] Blom AM, 2004, ARCH IMMUNOL THER EX, V52, P83
[8] Bora Nalini S, 2007, Chem Immunol Allergy, V92, P213, DOI 10.1159/000099272
[9] CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration
Bora, Nalini S.
Kaliappan, Sankaranarayanan
Jha, Purushottam
Xu, Qin
Sivasankar, Baalasubramanian
Harris, Claire L.
Morgan, B. Paul
Bora, Puran S.
[J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (03) : 1783 - 1790
[10] Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: Role of factor B and factor H
Bora, Nalini S.
Kaliappan, Sankaranarayanan
Jha, Purushottam
Xu, Qin
Sohn, Jeong-Hyeon
Dhaulakhandi, Dhara B.
Kaplan, Henry J.
Bora, Puran S.
[J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (03) : 1872 - 1878

← 1 2 3 4 5 6 7 8 9 10 →